Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Treatment of malignant pheochromocytoma with a new radiopharmaceutical

Journal Article · · Trans. Assoc. Am. Physicians; (United States)
OSTI ID:5764046
A new radiopharmaceutical, (/sup 131/I)metaiodobenzylguandine, concentrates in some malignant pheochromocytomas. Five patients were treated with two to four doses of (/sup 131/I)MIBG (99-197 mCi/dose). Two patients had substantial subjective and objective responses. (/sup 131/I)MIBG is the first chemically synthesized radiopharmaceutical of complex molecular structure to reduce cancer.
Research Organization:
Univ. of Michigan Medical Center, Ann Arbor
OSTI ID:
5764046
Journal Information:
Trans. Assoc. Am. Physicians; (United States), Journal Name: Trans. Assoc. Am. Physicians; (United States) Vol. 96; ISSN TAAPA
Country of Publication:
United States
Language:
English